Investment Summary

Summit Partners Invests In LumaBridge

On August 23, 2022, growth capital firm Summit Partners invested in life science company LumaBridge

Investment Highlights
  • This is Summit Partners’ 10th transaction in the Life Science sector.
  • This is Summit Partners’ 314th transaction in the United States.
  • This is Summit Partners’ 26th transaction in Texas.

Investment Summary

Date 2022-08-23
Target LumaBridge
Sector Life Science
Investor(s) Summit Partners
Deal Type Growth Capital

Target

LumaBridge

San Antonio, Texas, United States
LumaBridge is a specialty clinical research organization (CRO) focused on creating innovative clinical trial solutions for biopharma companies. LumaBridge was founded in 2014 and is based in San Antonio, Texas.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Summit Partners

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1984
PE ASSETS 39.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Summit Partners is a private investment and asset management firm focused on venture, growth, credit, and public equity investing. Sectors of interest include business services, communications technology and services, consumer products, energy, financial services, healthcare and life sciences, industrial products, internet/information services, media/entertainment, semiconductors, electronics, and software. Summit Partners is known for having a proactive business development group for sourcing transactions. Summit will consider both minority or majority investment stakes and is willing to commit as little as $10 million or as much as $500 million in combined debt/junior capital per transaction. The Firm's geographic coverage spans North America and Europe. Summit Partners was formed in 1984 and is headquartered in Boston, Massachusetts.


DEAL STATS #
Overall 376 of 387
Sector (Life Science) 10 of 10
Type (Growth Capital) 213 of 219
State (Texas) 26 of 26
Country (United States) 314 of 320
Year (2022) 8 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-28 PriceLabs

Chicago, Illinois, United States

PriceLabs is a provider of innovative and easy-to-use dynamic pricing and revenue management solutions for the accommodation industry. PriceLabs provides a data-driven approach, automation rules, and customizations to manage pricing and stay restrictions that help the owners and managers of vacation rentals increase revenues with efficiency and ease. PriceLabs was founded in 2014 and is based in Chicago, Illinois.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-11 Chronograph

Brooklyn, New York, United States

Chronograph is a provider of next-generation technology solutions for the private capital market. Through a suite of cloud-based analytics and data management solutions, Chronograph helps institutional limited partners and general partners – including many of the world’s largest private equity and venture capital investors – streamline and automate portfolio monitoring, valuations, analytics, and reporting. Chronograph was founded in 2016 and is based in Brooklyn, New York.

Buy -